144 related articles for article (PubMed ID: 10542889)
1. [Intraoperative chemotherapy with mitoxantrone and cisplatin after extensive debulking in the treatment of stage III and IV epithelial neoplasms of the ovaries].
Griggio L; Tasinato R
Tumori; 1999; 85(3 Suppl 1):S49-51. PubMed ID: 10542889
[No Abstract] [Full Text] [Related]
2. Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission.
Dufour P; Bergerat JP; Barats JC; Giron C; Duclos B; Dellenbach P; Ritter J; Renaud R; Audhuy B; Oberling F
Cancer; 1994 Apr; 73(7):1865-9. PubMed ID: 8137212
[TBL] [Abstract][Full Text] [Related]
3. Role of intervention surgery in stage III-IV epithelial ovarian carcinoma.
Hoogland H; Blijham G; Bron H; Eekhout A; van Geuns H; Haest J; Huiskes H; Kornman J; de Koning Gans H; Lalisang F
Prog Clin Biol Res; 1985; 201():213-5. PubMed ID: 3841592
[No Abstract] [Full Text] [Related]
4. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
5. Medical treatment of epithelial ovarian cancer.
González-Martín AJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338
[TBL] [Abstract][Full Text] [Related]
6. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
8. [Radical peritonectomy in 37 patients with stage II and III ovarian cancer].
Capretti PG; Zeppieri MC; Simonetti A; Rosato S; Lovotti D; Battaini A; Capretti G; Agnes Pradelli B
Minerva Chir; 2004 Jun; 59(3):233-41. PubMed ID: 15252388
[TBL] [Abstract][Full Text] [Related]
9. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer.
Cascales Campos PA; Gil Martínez J; Galindo Fernández PJ; Gil Gómez E; Martínez Frutos IM; Parrilla Paricio P
Eur J Surg Oncol; 2011 Jun; 37(6):543-8. PubMed ID: 21489742
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal carcinomatosis from ovarian cancer: cytoreductive surgery and intraperitoneal chemotherapy.
Tasinato R; Godina M; Biral M; Nicoletto O; Griggio L
J Chemother; 1999 Jun; 11(3):239-40. PubMed ID: 10435694
[No Abstract] [Full Text] [Related]
11. Primary treatment of epithelial ovarian malignancies.
McGuire WP
Cancer; 1993 Feb; 71(4 Suppl):1541-50. PubMed ID: 8431892
[No Abstract] [Full Text] [Related]
12. Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?
Tropé CG; Elstrand MB; Sandstad B; Davidson B; Oksefjell H
Eur J Cancer; 2012 Sep; 48(14):2146-54. PubMed ID: 22382201
[TBL] [Abstract][Full Text] [Related]
13. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
[TBL] [Abstract][Full Text] [Related]
14. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy in advanced ovarian cancer: a case-control study.
Loizzi V; Cormio G; Resta L; Rossi CA; Di Gilio AR; Cuccovillo A; Selvaggi L
Int J Gynecol Cancer; 2005; 15(2):217-23. PubMed ID: 15823102
[TBL] [Abstract][Full Text] [Related]
16. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
Tarraza HM; Boyce CR; Smith WG; Jones MA
Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
[TBL] [Abstract][Full Text] [Related]
17. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
Zhao XD; Zhang Q; Zhang Y
Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
[TBL] [Abstract][Full Text] [Related]
18. [The value of platinum dose intensity in first-line therapy on subsequent disease follow-up of epithelial ovarian carcinoma].
Gruböck K
Wien Klin Wochenschr; 1994; 106(11):362-6. PubMed ID: 8053205
[No Abstract] [Full Text] [Related]
19. [Advances in the treatment of ovarian carcinoma].
Pfisterer J; du Bois A; Hilpert F; Wagner U; Meier W
Dtsch Med Wochenschr; 2004 Feb; 129(8):379-84. PubMed ID: 14961446
[No Abstract] [Full Text] [Related]
20. The role of chemotherapy in the management of celomic epithelial carcinoma of the ovary.
Thigpen T; Vance R; Khansur T; Malamud F
Cancer Invest; 1997; 15(3):277-87. PubMed ID: 9171863
[No Abstract] [Full Text] [Related]
[Next] [New Search]